Israel, UAE quickest in Covid vaccine rollouts, push their markets to top

The race to deliver the jab to the world’s populations has so far been led by a handful of smaller nations, and now they’re outpacing some of the wealthiest countries in the eyes of traders too.

The fastest Covid-19 vaccination rollouts globally, in Israel and the United Arab Emirates, are propelling their equities to the top of the world in 2021. Israel’s benchmark TA-35 stock index has gained 7.6% this year, outperforming both the S&P 500 and the Euro Stoxx Index. And the Dubai Financial Market General Index has climbed about 9.8%, all but reversing its 10% slump in 2020.

Traders are rushing to price the global vaccine rollout and betting nations at the forefront will be the fastest to recover from the crisis, lifting their stocks, currencies and bond yields. The share of a country’s population that has been inoculated might be “the most important statistic to track over the next year,” according to strategists at JPMorgan Chase & Co.

So far, Israel has vaccinated about 30% of its population and the UAE about 20%. If sustained, they could reach the threshold for herd immunity by mid-year, JPMorgan says.

 

“Will enough divergence open up with respect to herd immunity across countries to render this issue tradeable across markets? Probably,” strategists led by John Normand wrote in a Jan. 8 note. “Those countries that return to pre-crisis levels of activity most quickly due to some combination of stimulus and vaccine distribution should witness the most upward pressure on their interest rates and currencies.”

While Israel and Dubai are tantalizing examples, the case for growth fueled by vaccinations in larger economies is murky, according to Michael Herzum, who runs macro strategies at Union Investment in Frankfurt.

“It is difficult to isolate these effects from other market drivers and therefore makes it difficult to play it on a country-by-country level,” Herzum said. Even so, he’s building vaccination rates into his cross-asset allocation decisions.

In Britain, where the first citizen outside of a trial received the coronavirus vaccination on Dec. 8, the FTSE 100 benchmark has outperformed peers in Europe even as its population suffers through a third national lockdown to quell a resurgence of the virus and a new fast-spreading variant. Vaccinations could pave the economy’s path to recovery and further lift the nation’s stocks, according to Herzum.

“U.K. equities could be in a good position very soon as the U.K. probably reaches herd immunity much faster than the continent due to much better progress on vaccinations,” he said. “This could result in a big swing in economic activity once Covid-19 related restrictions are lifted.”


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel